{"name": "New Haven Pharmaceuticals",
 "permalink": "new-haven-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/new-haven-pharmaceuticals",
 "homepage_url": "http://www.newhavenpharma.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "NHP",
 "email_address": "",
 "phone_number": "770-329-0074",
 "description": "",
 "created_at": "Tue Oct 30 02:07:21 UTC 2012",
 "updated_at": "Sat Apr 27 11:17:55 UTC 2013",
 "overview": "\u003Cp\u003ENew Haven Pharmaceuticals (NHP) is a specialty pharmaceuticals company developing proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications that represent significant market opportunities. The company\u0026#8217;s novel product pipeline employs proprietary, oral, controlled-release technologies, as well as intellectual property licensed from Yale University, which will enable optimal dosing, safety, efficacy and patient convenience.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       39],
      "assets/images/resized/0021/7827/217827v1-max-150x150.jpg"],
     [[250,
       66],
      "assets/images/resized/0021/7827/217827v1-max-250x250.jpg"],
     [[450,
       119],
      "assets/images/resized/0021/7827/217827v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$8M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.masshightech.com/stories/2012/10/29/daily6-New-Haven-Pharma-gets-6M-prepares-for-approval.html",
    "source_description": "New Haven Pharma gets $6M, prepares for approval",
    "raised_amount": 6000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 10,
    "funded_day": 29,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Connecticut Innovations",
         "permalink": "connecticut-innovations",
         "image":
          {"available_sizes":
            [[[145,
               83],
              "assets/images/resized/0002/3444/23444v1-max-150x150.jpg"],
             [[145,
               83],
              "assets/images/resized/0002/3444/23444v1-max-250x250.jpg"],
             [[145,
               83],
              "assets/images/resized/0002/3444/23444v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "EJ Funds",
         "permalink": "ej-funds",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Kuzari Group",
         "permalink": "kuzari-group",
         "image":
          {"available_sizes":
            [[[150,
               16],
              "assets/images/resized/0026/6563/266563v1-max-150x150.png"],
             [[250,
               27],
              "assets/images/resized/0026/6563/266563v1-max-250x250.png"],
             [[450,
               49],
              "assets/images/resized/0026/6563/266563v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Advantage Capital Partners",
         "permalink": "advantage-capital-partners",
         "image":
          {"available_sizes":
            [[[150,
               85],
              "assets/images/resized/0002/1156/21156v2-max-150x150.jpg"],
             [[205,
               117],
              "assets/images/resized/0002/1156/21156v2-max-250x250.jpg"],
             [[205,
               117],
              "assets/images/resized/0002/1156/21156v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "debt_round",
    "source_url": "http://www.finsmes.com/2013/04/haven-pharmaceuticals-receives-2m-venture-loan-facility-horizon-technology-finance.html",
    "source_description": "New Haven Pharmaceuticals Receives $2M Venture Loan Facility from Horizon Technology Finance",
    "raised_amount": 2000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 4,
    "funded_day": 26,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Horizon Technology Finance Management LLC",
         "permalink": "horizon-technology-finance",
         "image":
          {"available_sizes":
            [[[150,
               31],
              "assets/images/resized/0003/5674/35674v2-max-150x150.png"],
             [[250,
               52],
              "assets/images/resized/0003/5674/35674v2-max-250x250.png"],
             [[259,
               54],
              "assets/images/resized/0003/5674/35674v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "P.O. Box 586",
    "address2": "",
    "zip_code": "06437",
    "city": "Guilford",
    "state_code": "CT",
    "country_code": "USA",
    "latitude": 41.3395325,
    "longitude": -72.6978931}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}